Theravance Biopharma
TBPH
TBPH
119 hedge funds and large institutions have $369M invested in Theravance Biopharma in 2024 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 40 increasing their positions, 43 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
10% less funds holding
Funds holding: 132 → 119 (-13)
52% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 25
95% less call options, than puts
Call options by funds: $6K | Put options by funds: $110K
Holders
119
Holding in Top 10
4
Calls
$6K
Puts
$110K
Top Buyers
| 1 | +$19.1M | |
| 2 | +$8.06M | |
| 3 | +$2.12M | |
| 4 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$1.31M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$1.16M |
Top Sellers
| 1 | -$35.6M | |
| 2 | -$1.57M | |
| 3 | -$1.41M | |
| 4 |
HF
HRT Financial
New York
|
-$1.3M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.28M |